Aligos Therapeutics, Inc. (ALGS)

Aligos Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	18.66	37	135.7	81.35	186.82	220.38
Short-Term Investments	104.28	19.94	-	44.48	3.92	23.13
Cash & Short-Term Investments	122.95	56.94	135.7	125.83	190.73	243.51
Cash Growth	30.05%	-58.04%	7.85%	-34.03%	-21.67%	106.96%
Restricted Cash	0.11	0.11	0.07	0.12	0.16	0.56
Other Current Assets	4.89	5.09	5.31	7.6	13.53	5.94
Total Current Assets	127.94	62.14	141.08	133.55	204.42	250.02
Property, Plant & Equipment	6.12	7.33	9.82	12.51	14.97	14.91
Long-Term Investments	-	-	-	-	15.11	-
Other Long-Term Assets	0.64	0.63	0.63	0.63	0.87	0.38
Total Assets	134.71	70.09	151.53	146.69	235.37	265.3
Accounts Payable	3.94	2.57	2.52	4.74	3.02	3.31
Accrued Expenses	12.21	15.56	16.84	16.04	25.39	16.56
Current Portion of Leases	3.54	3.46	3.24	3.14	2.91	2.51
Current Unearned Revenue	0.58	0.15	1.31	9.21	7.64	7.89
Total Current Liabilities	20.27	21.74	23.91	33.13	38.96	30.27
Long-Term Leases	3.34	4.92	7.9	9.43	11.55	10.5
Long-Term Unearned Revenue	-	-	-	0.23	-	4.11
Other Long-Term Liabilities	9.24	72.41	27.64	-	0.13	0.38
Total Liabilities	32.84	99.07	59.45	42.79	50.64	45.26
Common Stock	0.01	0.01	0.01	0	0	0
Additional Paid-In Capital	692.22	588.58	578.33	502.61	487.35	394.96
Retained Earnings	-590.78	-618.01	-486.8	-399.12	-303.07	-174.74
Comprehensive Income & Other	0.42	0.45	0.55	0.4	0.45	-0.19
Total Common Equity	101.87	-28.97	92.08	103.9	184.73	220.04
Shareholders' Equity	101.87	-28.97	92.08	103.9	184.73	220.04
Total Liabilities & Equity	134.71	70.09	151.53	146.69	235.37	265.3
Total Debt	6.88	8.38	11.14	12.57	14.46	13.01
Net Cash (Debt)	116.07	48.56	124.57	113.25	176.28	230.51
Net Cash Growth	37.04%	-61.01%	9.99%	-35.75%	-23.52%	123.07%
Net Cash Per Share	14.82	7.75	48.59	66.31	110.57	576.95
Filing Date Shares Outstanding	6.15	6.11	3.03	1.72	1.71	1.53
Total Common Shares Outstanding	6.15	3.86	3	1.72	1.71	1.52
Working Capital	107.68	40.4	117.18	100.42	165.47	219.74
Book Value Per Share	16.56	-7.50	30.65	60.52	108.18	144.30
Tangible Book Value	101.87	-28.97	92.08	103.9	184.73	220.04
Tangible Book Value Per Share	16.56	-7.50	30.65	60.52	108.18	144.30
Machinery	8.19	8.04	7.91	8.28	7.48	6.23
Construction In Progress	0	0	0	0.02	0.02	0.07
Leasehold Improvements	6.1	6.1	6.1	6.09	5.94	5.66

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q